Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Matthias Ilmer"'
Autor:
Dominik T. Koch, Haochen Yu, Iris Beirith, Malte Schirren, Moritz Drefs, Yunfei Liu, Mathilda Knoblauch, Dionysios Koliogiannis, Weiwei Sheng, Enrico N. De Toni, Alexandr V. Bazhin, Bernhard W. Renz, Markus O. Guba, Jens Werner, Matthias Ilmer
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-21 (2023)
Abstract Background Despite recent advances in locoregional, systemic, and novel checkpoint inhibitor treatment, hepatocellular carcinoma (HCC) is still associated with poor prognosis. The feasibility of potentially curative liver resection (LR) and
Externí odkaz:
https://doaj.org/article/89af6ca6afb242988daf6262b04f125d
Autor:
Julian Kolorz, Salih Demir, Adrian Gottschlich, Iris Beirith, Matthias Ilmer, Daniel Lüthy, Christoph Walz, Mario M. Dorostkar, Thomas Magg, Fabian Hauck, Dietrich von Schweinitz, Sebastian Kobold, Roland Kappler, Michael Berger
Publikováno v:
Current Oncology, Vol 29, Iss 1, Pp 94-110 (2021)
Rhabdoid tumors (RT) are among the most aggressive tumors in early childhood. Overall survival remains poor, and treatment only effectively occurs at the cost of high toxicity and late adverse effects. It has been reported that the neurokinin-1 recep
Externí odkaz:
https://doaj.org/article/b4d76b70588949f19417df65d47f2b16
Autor:
Ulrich Mansmann, Jens Werner, Bernhard W Renz, Christine Adrion, Carsten Klinger, Matthias Ilmer, Jan G D’Haese, Heinz-J Buhr
Publikováno v:
BMJ Open, Vol 11, Iss 11 (2021)
Externí odkaz:
https://doaj.org/article/e11d263d78e94b65a935bda262de1c2e
Autor:
Stephan Kruger, Matthias Ilmer, Sebastian Kobold, Bruno L. Cadilha, Stefan Endres, Steffen Ormanns, Gesa Schuebbe, Bernhard W. Renz, Jan G. D’Haese, Hans Schloesser, Volker Heinemann, Marion Subklewe, Stefan Boeck, Jens Werner, Michael von Bergwelt-Baildon
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-11 (2019)
Abstract Immunotherapy has become an established pillar of cancer treatment improving the prognosis of many patients with a broad variety of hematological and solid malignancies. The two main drivers behind this success are checkpoint inhibitors (CPI
Externí odkaz:
https://doaj.org/article/865820d276074436bcd7e20f3bbb04c3
Autor:
Sebastian Wolf, Verena S. Hoffmann, Florian Sommer, Matthias Schrempf, Mingming Li, Martin Ryll, Ulrich Wirth, Matthias Ilmer, Jens Werner, Joachim Andrassy
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 14, p 4216 (2022)
(1) Background: Following renal transplantation, infection with cytomegalovirus (CMV) is a common and feared complication. mTOR-inhibitor (mTOR-I) treatment, either alone or in combination with calcineurininhibitors (CNIs), significantly reduces the
Externí odkaz:
https://doaj.org/article/c8693a1cc42843eb89963701d6dbc134
Autor:
Matthias Ilmer, Markus Otto Guba
Publikováno v:
Cancers, Vol 14, Iss 11, p 2662 (2022)
While liver transplantation was initially considered as a curative treatment modality only for hepatocellular carcinoma, the indication has been increasingly extended to other tumor entities over recent years, most recently to the treatment of non-re
Externí odkaz:
https://doaj.org/article/0b18411fa78840ecab038b564f162c6d
Autor:
Tianmiao Ma, Bernhard W. Renz, Matthias Ilmer, Dominik Koch, Yuhui Yang, Jens Werner, Alexandr V. Bazhin
Publikováno v:
Cells, Vol 11, Iss 2, p 310 (2022)
Myeloid-derived suppressor cells (MDSCs) are one of the main suppressive cell population of the immune system. They play a pivotal role in the establishment of the tumor microenvironment (TME). In the context of cancers or other pathological conditio
Externí odkaz:
https://doaj.org/article/3d90cd97d3c84a80abdd1dc9fbfe3a52
Autor:
Iris Beirith, Bernhard W. Renz, Shristee Mudusetti, Natalja Sergejewna Ring, Julian Kolorz, Dominik Koch, Alexandr V. Bazhin, Michael Berger, Jing Wang, Martin K. Angele, Jan G. D’Haese, Markus O. Guba, Hanno Niess, Joachim Andrassy, Jens Werner, Matthias Ilmer
Publikováno v:
Cancers, Vol 13, Iss 11, p 2703 (2021)
The SP/NK1R-complex plays an important role in tumor proliferation. Targeting of the neurokinin-1 receptor in previous studies with its antagonist aprepitant (AP) resulted in anti-tumoral effects in colorectal cancer and hepatoblastoma. However, ther
Externí odkaz:
https://doaj.org/article/da0e5db682d240819bb70989e312974e
Autor:
Ulrich Wirth, Debora Garzetti, Lara M. Jochum, Stefanie Spriewald, Florian Kühn, Matthias Ilmer, Serene M. L. Lee, Hanno Niess, Alexandr V. Bazhin, Joachim Andrassy, Jens Werner, Barbara Stecher, Tobias S. Schiergens
Publikováno v:
Cancers, Vol 12, Iss 12, p 3702 (2020)
The role of gut microbiota in colorectal cancer is subject to extensive research. Before usage of biorepositories for microbiome studies, it is crucial to evaluate technical feasibility of microbiome profiling from various biospecimens. The aim of th
Externí odkaz:
https://doaj.org/article/11426210703d4481922329f4c720f384
Autor:
Ulrich Andergassen, Simone Hofmann, Alexandra C. Kölbl, Christian Schindlbeck, Julia Neugebauer, Stefan Hutter, Verena Engelstädter, Matthias Ilmer, Klaus Friese, Udo Jeschke
Publikováno v:
International Journal of Molecular Sciences, Vol 14, Iss 1, Pp 1093-1104 (2013)
It is widely known that cells from epithelial tumors, e.g., breast cancer, detach from their primary tissue and enter blood circulation. We show that the presence of circulating tumor cells (CTCs) in samples of patients with primary and metastatic br
Externí odkaz:
https://doaj.org/article/1a5f7d98021046c6933fb703c44d06a8